PROGRAMME

Session 1	Epidemiology of primary HIV drug resistance and viral subtypes
Session 2	Mother-to-Child transmission and drug resistance
Session 3	Resistance to new antiretrovirals
Session 4	Clinical applications of HIV resistance testing after treatment initiation
Session 5	HIV replicative capacity/ fitness
Session 6	Drug resistance, medication adherence and therapeutic drug monitoring
Session 7	Interpretation of genotypic resistance
Session 8	Viral co-infections and co-resistance